C

ChoA Pharmaceutical Co Ltd
KOSDAQ:034940

Watchlist Manager
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Watchlist
Price: 992 KRW -0.8% Market Closed
Market Cap: 30.7B KRW

ChoA Pharmaceutical Co Ltd's latest stock split occurred on Jul 5, 2005

The company executed a 2528-for-2435 stock split, meaning that for every 2435 shares held, investors received 2528 new shares.

The adjusted shares began trading on Jul 5, 2005. This was ChoA Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Apr 21, 2003.

Last Splits:
Jul 5, 2005
2528-for-2435
Apr 21, 2003
10-for-1
Pre-Split Price
N/A
Post-Split Price
4 315
Before
After
Last Splits:
Jul 5, 2005
2528-for-2435
Apr 21, 2003
10-for-1

ChoA Pharmaceutical Co Ltd
Stock Splits History

ChoA Pharmaceutical Co Ltd Stock Splits Timeline
Jul 5, 2005
Jul 5, 2005
Split 2528-for-2435
x1.0381930184805
Pre-Split Price
N/A
Post-Split Price
4 315
Before
After
Apr 21, 2003
Apr 21, 2003
Split 10-for-1
x10
Pre-Split Price
N/A
Post-Split Price
4 315
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.46 8.46 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Dec 30, 2025
Adicet Bio Inc
NASDAQ:ACET
1-for-16
/16
0.4921 0.4921 USD 7.93 7.93 USD
Load More

ChoA Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B KRW
Industry
Pharmaceuticals

ChoA Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. The company is headquartered in Seoul, Seoul. The Company’s products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. The company also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.

Intrinsic Value
1 765.41 KRW
Undervaluation 44%
Intrinsic Value
Price
C
Back to Top